干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
干细胞之家 - 中国干细胞行业门户第一站 › 干细胞之家论坛 › 干细胞文献资源库 › 经典PDF电子书下载区 › 再来一本病毒学经典--Virology:principles and applicat ...
中源协和

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 1126779|回复: 334
go

[干细胞与细胞生物学类] 再来一本病毒学经典--Virology:principles and applications--John B. Carter   [复制链接]

Rank: 4

积分
1343 
威望
1343  
包包
387  

金话筒 优秀会员 热心会员 小小研究员 积极份子 帅哥研究员

楼主
发表于 2011-7-14 17:27 |只看该作者 |倒序浏览 |打印
干细胞之家微信公众号
本帖最后由 细胞海洋 于 2011-7-14 22:01 编辑 " s, V- V. @4 t% @& r2 l

- z/ A- q9 f. a* `# O! T [hide][/hide]6 o; d; @5 i" U' u# b: Z
Virology - Principles and Applications; V( {! @4 P; w, E2 Q
Dr John Carter (Liverpool John Moores University, UK), Prof Venetia Saunders (Liverpool John Moores University, UK)' y' g" ]1 l/ ~; [) t
August 2007, ©2007
$ j6 \, H; f* Y( a4 B7 A$ Yby Dr John Carter, Prof Venetia Saunders
8 v* B% I9 s/ v9 b' R. bISBN 978-0-470-02387-7. ~9 ]- S5 H7 f: O& J
Preface.
% I4 x- J7 j4 [3 {) D
% |4 M3 C8 I8 B3 jAbbreviations used in this book.: j- y# X; R+ |- F
8 x* j- V9 a6 Y% Z1 [+ U
Greek letters used in this book.
$ E6 A4 k1 F- X* t8 a0 {( X
8 u: l9 \; P, z4 P" k0 V; AColour coding for molecules.. G1 Y! q1 W) W4 @
* n3 ~5 v4 h' x0 D! c! O$ [
1 Viruses and their importance.- e  x: ^3 t, A, X$ W  M7 A) r
3 j' C- ]; `- i7 j$ |$ ^- Z" Z4 h' C) T: r
1.1 Viruses are ubiquitous on Earth.
$ M+ S7 R* \6 R+ s$ a6 R) |: D2 o% `6 _# R. Q" ~  x
1.2 Reasons for studying viruses.; {! k! B: C! ?1 z. ?
2 J& }" I2 L/ N( F# S* r
1.3 The nature of viruses.
- o# v$ u6 s+ r0 @  [
5 M7 H+ T3 h( {1.4 The remainder of the book.
! k! _8 C4 S, t! ^9 ]
& a8 n$ G" `% j7 G3 r/ c2 Methods used in virology.
' \7 P* G% {- n
4 k( P* c: B/ i0 m# K! ]( s2.1 Introduction to methods used in virology.6 p' ?" J, C* H; n
. e$ B  U) O5 c1 D$ L
2.2 Cultivation of viruses.' v6 A: D* Z9 i6 r+ v7 ~
4 Y! ?, z0 V0 ~( X
2.3 Isolation of viruses.
  _6 I9 Y  T: b
6 B3 X& x' m" j8 P2.4 Centrifugation.
6 u& X# Q7 x/ G9 R' \! C) P# Z: n. H9 d; Q; R
2.5 Structural investigations of cells and virions.
% ?6 r( J) c- \9 y3 l: g
: w5 W/ S. o/ o* A) O2.6 Electrophoretic techniques.
' ^# z9 o. G$ k5 D
# [, a- S6 c% \, `2.7 Detection of viruses and virus components.. j1 E+ c. z- J$ |) o2 G
! @# P) \. j6 t% c8 C
2.8 Infectivity assays.
  v/ V1 c2 {, f! E: U: x  S  p" a- U- n( M3 X3 R
2.9 Virus genetics.
0 N( B% m, O. [: g# U! y  d( w( T, ?' W& |( q
3 Virus structure.3 q" i& \: A: o2 a

) r% @6 X# v5 g3 j3 ^7 _3.1 Introduction to virus structure.
6 N0 u5 U1 k# B! W0 v. i3 }; h7 Q: e  }! S4 ~
3.2 Virus genomes.
3 J) y3 i( g4 w/ l; T7 e1 S7 F; ^1 r7 F
3.3 Virus proteins.
' D+ I0 c4 ]- t" k. ?; A- K# v, f- s
3.4 Capsids.
0 w* T$ ?) K- `0 r# p
0 @; T! `0 ?* s* ^! @. R3.5 Virion membranes.
$ [# T& q1 v1 p! f  J  j# h: q4 e; h2 _$ ?4 u% C8 k
3.6 Occlusion bodies.' y( S' I6 x- O! p" o. n( B1 r
6 u( R5 F) @4 z3 M1 W. C
3.7 Other virion components.; O* |+ k5 e& M% W9 @. }5 _

% W  t/ w% K# R4 Virus transmission.
, p, R$ h9 ?* A/ j2 ?) {. D* s  D2 ]
4.1 Introduction to virus transmission." }7 k4 _) t* N2 z2 ^4 I5 b% b8 {

- k& s, J: S6 u1 r# u# l) W9 Y4.2 Transmission of plant viruses.( ]- h2 j: D! I* p. C7 l/ ]

. p; {! m9 N* J* x4.3 Transmission of vertebrate viruses.
" G$ H( z3 h% b) R) e9 z. z1 u: b. t' y) ?( |7 ]$ w
4.4 Transmission of invertebrate viruses.
4 r/ r* y5 |/ i8 j7 c6 y& g9 i- [, T) n
4.5 Permissive cells.
; e- `7 a) i, k2 J- L
1 n& \. B: f, d' S% D7 s3 l# o5 Attachment and entry of viruses into cells.( e1 K) B' L  S. p6 S) j* U- ~
! D( A. A7 @, C- \: [4 Q
5.1 Overview of virus replication.7 r/ W, \/ e9 q1 @0 A
+ ?  c/ V% j( J) H$ |; a& b! A# i
5.2 Animal viruses.7 Z6 y) R/ l1 c

1 Y4 H) B2 J4 W5.3 Bacteriophages.
' D& u$ j" ]  T, ^  a
$ D& W' m, f5 r$ q6 Transcription, translation and transport.1 K8 Z; Q2 {! o

/ s! s- L( B; k+ H3 F: r6.1 Introduction to transcription, translation and transport.
0 `# s5 T; L6 A% R
3 @1 l" f& N# F. z' g: g6 f6.2 Transcription of virus genomes.
3 U* X  D8 F( J/ V% N# m6 a0 e6 }% t! |, p5 c
6.3 Transcription in eukaryotes.0 ^7 M4 A5 O: x( d; H% [; s7 \

, G3 {% j& t. A9 b* u6.4 Translation in eukaryotes.1 D5 V5 A$ K7 s, @- q/ o0 D8 a3 f

" E. a4 Y  b( `: |6.5 Transport in eukaryotic cells.
1 n' `2 z2 x' E* X
! Z( G! a' S' [, P# G: P6.6 Transcription and translation in bacteria.
5 I( H0 V2 l6 l) J
5 ~0 s* A: S$ n* p7 Virus genome replication.( V. J9 q. B6 T2 h

1 s& k1 i6 a" R2 `0 H7.1 Overview of virus genome replication.2 Z' F7 y6 N5 G/ I# V" Y

; |5 n+ {0 b5 i3 V* ^" x5 k6 V& g/ G2 J7.2 Locations of virus genome replication in eukaryotic cells.  F, Z5 V$ B" _1 @

& |( W8 @+ O' O; o5 Q) K# w: j7.3 Initiation of genome replication.
) {  m  [  R( Z6 |4 S3 b
! j7 R+ H# g- S. J% Q7.4 Polymerases.
2 r- n# ^: W* `4 ]* L, o7 X( O# ^! I, {( |# W1 P0 k
7.5 DNA replication.
/ P- f5 I( X% n
6 u, }2 x) x! A* S; H6 c7.6 Double-stranded RNA replication.
, C) U7 y# Y. \; m# z0 `
1 A. E; w+ A) j6 K7.7 Single-stranded RNA replication.
4 U2 i0 z+ K$ ?
0 c1 \, p+ Q' W8 l% `7.8 Reverse transcription.
5 x3 c7 H) J( N  [! {1 a* t
) T* i6 c5 `8 q" k* {8 E! F8 Assembly and exit of virions from cells.
4 s  v  c* \4 L3 ^* l! q1 l, ^
( r) |9 g2 A) I5 [  C6 D# p! }8.1 Introduction to assembly and exit of virions from cells.
) z3 N  C: y9 q. E1 Y* z* f6 Q- z4 M& s2 W; |7 `7 M0 [: Q
8.2 Nucleocapsid assembly.. K6 Q9 I& Y* _" F: E! Y+ w

$ L, R$ O, O, E2 |8.3 Formation of virion membranes.% f6 w/ B! O) S: S- q. G

0 x% ?# Z# A9 W* c. t  @+ W8.4 Virion exit from the infected cell.
/ S7 {2 n9 X+ j1 G! e' b
+ Y' W" q( V2 G- D- P9 Outcomes of infection for the host.
* G0 w) \) x  K$ g! o4 v6 O& O; q/ l3 g" p
9.1 Introduction to outcomes of infection for the host.) ^0 y! J7 f* x; ~

0 t. f1 u( {9 a" M8 e9.2 Factors affecting outcomes of infection.
* {: r" D) t, Z" L' p7 f+ @: p7 ~4 j2 D" R. D7 K
9.3 Non-productive infections.. ]7 f3 \# d3 R7 B! c
9 V5 R7 X- [  d+ m6 f
9.4 Productive infections.5 n9 x8 G& l8 f+ h9 H

. ]9 U5 E- f, ^0 U" |# A5 F, m) S9 m! i10 Classification and nomenclature of viruses.
* b) m2 l; x2 [8 y) `  I5 l+ {3 C. c1 U
10.1 History of virus classification and nomenclature.# g+ q; A% S) G0 ~' g, K
4 i- A1 }( Z/ U2 f1 U4 u2 c
10.2 Modern virus classification and nomenclature.
" j" D/ M  U0 U3 u
4 T9 Q6 K6 S" {: Z5 P# C3 C10.3 Baltimore classification of viruses.0 e& h9 ?1 r1 _7 r- p

' v4 q( m( e5 _11 Herpesviruses (and other dsDNA viruses).
3 q) L; V$ c1 q1 S, O
! Q4 x8 E$ K; s( ~11.1 Introduction to herpesviruses.5 {9 J# P+ A2 u0 v$ J" h7 d

" Y- o. U* X* r; h+ b8 q11.2 The human herpesviruses.
5 F: W% R% m) _/ b2 L9 Y* ?) u8 [4 T6 w
11.3 The herpesvirus virion.3 e$ H. o$ r$ O5 t, |% A+ l% `

: u# z% I* @: E$ B# D/ F11.4 HSV-1 genome organization.
$ h, r6 h* A" A/ A! l# R, e
6 j8 s# E2 k; j6 ?3 g  y11.5 HSV-1 replication.
& L2 t8 T5 ~& J! h  c& Y$ y  e0 R' B  f3 c2 n+ j- Z
11.6 Latent herpesvirus infection.
9 F: T( s+ B8 m5 [1 c8 `9 W( r! V0 _; S, z: J# ]" q3 \
11.7 Other dsDNA viruses." v, ?' T; O2 ]6 N( i
( A) @3 l3 R2 n+ X, ]
12 Parvoviruses (and other ssDNA viruses).1 _7 F7 ^( t* d0 T% t) n9 O
3 J* A. Z) Q# Z% t& Y2 l9 i
12.1 Introduction to parvoviruses.) F* ?5 A  J$ M" a
# }6 G. H; c% G: J3 _6 l! q
12.2 Examples of parvoviruses.
9 E6 P+ }4 S4 I2 y
9 D! o  |% p  e& {+ u12.3 Parvovirus virion.4 Y/ y; l8 F* u& a

: q! u0 b, H: t12.4 Parvovirus replication.$ g% J; Z  x9 b6 b

3 {9 V7 _. H9 J" _6 u& d12.5 Other ssDNA viruses.' G; X$ k) J) S8 n

* N/ Q! Y' ~4 M+ }1 r2 e: @: S13 Reoviruses (and other dsRNA viruses).
- Q+ q& K2 b% q6 U7 n  D3 O( t4 z1 W! ]4 }- \. R1 o4 |
13.1 Introduction to reoviruses.
- b: W4 j# y5 f) @& p, A/ Y0 k5 e8 i
13.2 Rotavirus virion.
; b9 u: z# r" N; ]0 T8 ^" d
1 X& s* @2 N7 ~( E4 ?7 K1 q; Z13.3 Rotavirus replication.4 Y3 g. V; B- k

! T7 R7 q; n1 O13.4 Other dsRNA viruses.6 \( N/ k: t7 q
' c3 K& o0 K% k, a
14 Picornaviruses (and other plus-strand RNA viruses).: h5 Z) z* s' o8 w0 A3 H) w$ O2 E

/ X4 C4 |# V5 b14.1 Introduction to picornaviruses.; Q0 h! x9 R" ?* L: }( m: w5 O

" n+ m& ]& s8 Y* Z7 ?' V14.2 Some important picornaviruses.9 N( r) h$ E* n$ O) y
" N0 E7 ?) ~4 D; c( a
14.3 The picornavirus virion.
5 Y( Y' u; ]1 g0 _: |- z2 q  c5 ^4 t4 S1 V  v+ F
14.4 Picornavirus replication.$ i7 n! a3 K+ S
* ]& K+ Q3 r1 A; A. Y( Z6 W
14.5 Picornavirus recombination.
- C% C& X+ ~1 c2 f2 A
: i% T% v9 O# I7 Y# J; x9 T+ Q14.6 Picornavirus experimental systems( B; A+ ?8 W4 j, u, t

; T' \  h/ j' K* \7 y7 a14.7 Other plus-strand RNA viruses.
! L: e8 h0 p/ |! U$ o* v7 K- [
15 Rhabdoviruses (and other minus-strand RNA viruses).5 T7 z# A; I* a7 z8 h! K3 V( T7 Y6 ^

( e: w$ b- c$ K, P3 G3 f: x2 p15.1 Introduction to rhabdoviruses.
& x& a/ t. I0 \6 l9 @
- p+ C6 a6 w0 l6 `' y15.2 Some important rhabdoviruses.
! k% L+ Y  J6 Q4 x) Z* f) r; `' U* }) l9 r/ D1 i5 `3 Q
15.3 The rhabdovirus virion and genome organization.
5 l# E$ O% R3 _% O' `% C+ Z- o8 n; H% m3 S
15.4 Rhabdovirus replication.
- F. f% F% q* V3 D
* l0 M( h. W: D( w15.5 Other minus-strand RNA viruses.
* s5 V: }$ y# z) C  }8 N6 ?! w
3 G! G( z+ i* P% U1 O15.6 Viruses with ambisense genomes.. I; X% M. l8 A! Q) O: P
* M% y, ?* O0 P; D+ B
15.7 Reverse genetics.$ a% ^) t: h3 V& a; ~" m2 D
# W4 x: @/ J$ t) w) g  u  j, O1 G3 [# n
16 Retroviruses.: ]5 H6 E; c6 W+ [  E

% e2 Z* x$ J6 ?9 N16.1 Introduction to retroviruses.
& g5 A5 Y0 k( f. u8 P4 L+ ?. ~, ?3 X  i, p8 }
16.2 Retrovirus virion.) p7 ~# f/ c& u: r) d/ n

0 U0 w0 {/ q3 f% n; s16.3 Retrovirus replication.
0 v; b" H0 P# w! S0 W
' E) r' v1 _/ d  H: X16.4 Examples of retroviruses.
  h. [9 {7 K" r8 U& A2 _  e% v/ x: j& [; r/ _
16.5 Retroviruses as gene vectors.
3 ]  O( M# ?3 t5 \, K" c5 [
' g* a" E  \& L* s4 H16.6 Endogenous retroviruses.0 x& E0 s3 h# L$ a- O
8 |, y9 `- p+ V- ~/ V- `2 f, [
17 Human immunodeficiency viruses.
/ k- f. f  y3 `5 t' G* R4 S- m" _8 C% }1 H
17.1 Introduction to HIV.
+ v& h  _# e: M+ j
) ^: u. d0 C, F9 v! V$ s17.2 HIV virion.4 Z. }8 h) o. h
- ^) X; v; w- T6 ]8 g2 Q, y
17.3 HIV genome.
# ]' E3 m$ W; l/ d* y+ x- D1 r/ e+ B, H( Q7 H3 Y& I
17.4 HIV-1 replication.( O6 ?9 K" Y5 g

$ j' h4 m9 r' {8 m" l3 o; p; R3 L17.5 HIV-1 variability.
' Y8 j9 D- w$ M, t- E- N/ t( W3 v8 c: d2 V
17.6 Progression of HIV infection.
- x* }* ^6 K. w9 E! n
% a- Y# V( L+ `& b* L% l17.7 Prevention of HIV transmission.
1 b- V5 c5 W( J, \2 I; i
" c, |7 B0 R  G( k" R18 Hepadnaviruses (and other reverse-transcribing DNA viruses).
; K  B9 R8 i  {! I4 ]' X- X5 z  v8 F; o
18.1 Introduction to hepadnaviruses.
. D" B: y; y: ^) a, r" i. _
, N/ @+ e- c+ q18.2 Importance of HBV.
0 Z6 E  F  d" ~( }, M
: D5 F9 X, E1 o1 \3 a, ?5 `+ t0 i18.3 HBV virion.* @& M' J( h) D0 T1 H. V0 ]* [

& b  _' l* g- W2 ^5 x4 J5 x  ^18.4 Non-infectious particles.
3 b& ?6 D( ~# F8 r  P% \8 {; L+ _* l; ]  B4 Z; u. T6 p/ |
18.5 Soluble virus protein.9 s  L; l0 z8 U# k
" c- y# d" d/ f6 H9 |
18.6 HBV genome.8 O/ [6 G% f6 Z  K
* p' {; b& o% N& P
18.7 HBV genetic groups./ N8 z" |8 i' ^# d% W
9 j& Q( b$ \0 j5 h0 M- \: t
18.8 HBV replication cycle./ X& q1 a& |% w

( z. P$ I- @9 c* t" u1 K" w1 f18.9 Prevention and treatment of HBV infection.* L/ r1 @8 a: L. P0 K
* V% X* J. i: o4 X+ x( x
18.10 Other reverse-transcribing DNA viruses.. A& N$ z4 l" F* y: J" K, Q+ C2 O8 A

  R  v/ Z/ I! }# M9 i+ _5 S19 Bacterial viruses.
( I$ U' D: ~7 q+ q( E
4 \9 o& s7 p9 J" ^7 o19.1 Introduction to bacterial viruses (bacteriophages.
+ ?; n0 x, P1 a) `# X
# q2 w) H1 D2 _0 U/ z+ Y3 j4 J( b" NRNA PHAGES.
8 Z/ e, L) A' h: n' G+ T
- p( n4 P' u% ], O7 s% Q$ L19.2 Single-stranded RNA phages.4 o- O3 x: H4 ~# z# f3 A+ b

9 x4 _0 J1 |# a  E6 E. X1 V19.3 Double-stranded RNA phages.
9 c4 m$ F5 d9 C- o; \! m. ~/ J' g
( n2 Z$ f$ N2 d6 r" Y) IDNA PHAGES.3 J0 B. G( V- |( {) ^( l: E
! `6 A+ `; s& l' U. @2 O
19.4 Single-stranded DNA phages.
: C4 h$ t# y  l+ U1 {
1 f: B% _( l) P19.5 Double-stranded DNA phages./ u1 I# ^5 A; P
# x7 d& K/ p! W. {
20 Origins and evolution of viruses.
9 m9 Q8 f9 a* r2 k. x0 E' N; [$ y3 T, c2 f6 l$ d! U1 P6 d- c
21.1 Introduction to origins and evolution of viruses.
! R) _5 C  Y" K3 v" q. p& Q' o: P* W
20.2 Origins of viruses.
& k, n1 b/ [: z6 d6 s: }0 I
. S) @0 m  }" z- P: G: F; |20.3 Evolution of viruses.8 B5 o; D# k, u" [' t3 A3 H
/ v% U! i2 A! l9 `& `) }6 O" h0 F
21 Emerging viruses.& _. z- H: Y! t  k7 ^

" _* c' M" m+ ?( r6 m+ ^0 f21.1 Introduction to emerging viruses9 v  R% f* L, h7 ]$ l. {
5 t  M" a) z- W3 E1 Y( t5 |
21.2 Viruses in new host species7 h) ]' A- \$ ~! T
& ~  c# ?: A8 b+ _
21.3 Viruses in new areas: I3 K! o) b6 y# r0 x

5 h3 _5 s. _* r; u5 r, T/ u' Q( d21.4 Viruses in new host species and in new areas6 a+ d6 n& S4 N& Z9 Y2 k# w8 Q$ s

8 e0 @1 m& C4 g: C6 E- \  p21.5 New viruses
, t! V* ~; e( E8 ?5 w7 S3 Y/ v2 A6 n! K: q
21.6 Recently discovered virus
  s$ O1 t. @) e2 j2 B4 J' ~' }( k
21.7 Re-emerging viruses7 |4 p$ a9 i  w- S  @

0 x9 u1 E6 [$ t21.8 Virus surveillance
9 u2 U" F9 r+ A# d( t" q3 \6 N# ]
21.9 Dealing with outbreaks
- g% K- Q! {+ o+ A9 w; r. z% E- y7 O/ W3 T7 K& m7 d  n
22 Viruses and cancer. a& b. b& S3 I
0 S: F- D$ l2 i1 m( S
22.1 Introduction to viruses and cancer- n. r  K" _5 q5 O" X

: t3 o0 g; |% A3 N$ Z3 k22.2 Papillomavirus-linked cancers
+ O: F  Q- _& e* C. n5 J( i* S" G
7 B8 |% B% u1 [) m9 c: l/ ]22.3 Polyomavirus-linked cancers3 c/ P" |. h! q/ \$ C2 N- i
. k7 i- x& A6 E- ^- t) m6 }
22.4 Epstein-Barr virus-linked cancers
3 q1 A' t6 O9 k- [- P5 Q! p/ x0 }6 h& U; w4 ?7 C# T
22.5 Kaposi’s sarcoma
3 G, t. m+ D- l' M" {% t* W8 V( U! V* L6 ]( U  j" X. }
22.6 Adult T cell leukaemia" L" b; o/ x& \) v

2 `4 ~% B. ^" s& i! C: o4 z9 K+ Y+ \22.7 Hepatocellular carcinoma
0 i4 V0 W: C! T' S& M% |; w# `2 ?7 `# T/ u- N; q8 X
22.8 Virus-associated cancers in animals+ X1 A5 G% T3 n5 L
7 v7 I' {: ?. N. p0 N
22.9 Cell lines derived from virus-associated cancers.# l# N; r- d- ~: _7 c/ R7 K+ H3 l
4 [3 ]4 L/ e5 Q5 L
22.10 How do viruses cause cancer?
( U+ N& E% q( A4 t& J. S% _7 {  b- g& n3 H: T& S9 r
22.11 Prevention of virus-induced cancers.& a, x4 G  v( D

$ @7 _+ D) e- x' C23 Survival of infectivity.& z2 G4 N6 m  _9 n. D" F$ S
! e2 D) m3 E% l4 w6 j
23.1 Preservation of virus infectivity.9 O2 z( W5 S/ Q
  `$ _, F# |4 f8 X9 _
23.2 Destruction of virus infectivity.
$ I$ p5 \0 X8 C( k) M  p7 G# }( A0 Q! v  y
23.3 Inactivation targets in virions.
( b) a+ J7 I) _9 ?
/ V; I. R8 y- n$ b0 p5 y23.4 Inactivation kinetics.
& k8 G3 Z  V9 x' M& b! M5 t
- w% N1 L0 q, U6 y0 }23.5 Agents that inactivate virus infectivity.
& e) t' r. e& B! ^1 A6 _% U4 m; E  e4 B
24 Virus vaccines." K+ j& D! {2 W# K: |
' C1 D4 ^4 r; Z  @$ _5 c0 J- p
24.1 Introduction to virus vaccines.
0 d' ]3 J  B( B; f, L, z% ]8 i* ?3 h
24.2 Live attenuated virus vaccines.
. a! \' {% t# _: `# F
9 B3 s; Z! O5 y; f, L+ j2 N24.3 Inactivated virus vaccines.
, }8 T: Y" K3 H( I4 O6 n) S  k
* d( C) \6 A; s9 o  P0 F24.4 Virion subunit vaccines.
  I) a& \0 p4 G7 f) ?. }; j: \; S# c! K$ [/ M; q2 L2 C: w2 L8 G
24.5 Live recombinant virus vaccines.% m6 L5 S7 V7 @( S5 e: L
% S( n- Z$ g& A! e
24.6 Mass production of viruses for vaccines.
- R" b+ p7 Y: l1 D, t7 }( v9 O& V- f( y5 X
24.7 Virus-like particles.3 z" w% I2 ^* K' b5 t
- Q  b  u6 U* t& J# ]2 l
24.8 Synthetic peptide vaccines.6 x7 w% M* y; V' x% B) X3 i

# }. u- L. y0 ~6 y9 ]2 K# |24.9 DNA vaccines.
+ b& ^6 L3 Y1 |  \2 }3 D1 x3 Y' K  d" t& s8 C, T5 q
24.10 Storage and transport of vaccines.
8 A7 Y, Y, o2 T: b8 a% s; _6 N; S' d' P3 o8 Z" b. w: U8 t
25 Anti-viral drugs.
5 j7 ^0 U. _5 `! r
! e( M$ A2 A4 }9 |* R+ `25.1 Introduction to anti-viral drugs.
( F; f# C7 p$ ]# f: H0 z3 u/ a, s% j+ k' J9 `% b& n$ z8 ]; \
25.2 Development of anti-viral drugs.. P: x3 @! d- p/ q0 u7 Y7 v
/ a) D* K( i+ V+ @
25.3 Examples of anti-viral drugs.* `; @4 s) q, L, }+ X5 E

' d: S0 k/ D! L25.4 Drug resistance.
8 K% l) `; H' @7 ^6 d3 }
* N: u: A$ R$ H& y1 ^* F7 G25.5 Anti-viral drug research.
9 {9 @: D- I  w1 w4 S3 r4 W; c0 n
% [% D/ q/ }+ A6 O26 Prions.
5 I# ]; D3 }6 z% e+ I
) X' @3 l* `! M* b/ o+ _26.1 Introduction to prions.
" u: X' v) Q: k- b4 G& y
1 v9 z+ A  V% K1 u' ^6 y26.2 Transmissible spongiform encephalopathies.2 Q* \6 f0 H( z' \" I5 O

: Y  N$ B  W2 F( S26.3 The nature of prions.2 |% I* r4 X2 [$ @1 p
) T: `, c: @9 q8 J4 K
26.4 Prion diseases.
1 k/ |, w5 r( v; L4 o# B9 n* N+ W2 b) h- h, N( [, L! w; N3 S8 t2 P
26.5 Prion strains.
1 Y, _+ K0 k% b) d
3 @9 P3 c' k* u/ S, a26.6 Prion transmission./ O; ~' K  A" e9 _( t4 C; [

& f% N2 y4 @4 o8 Q% j1 A5 ]26.7 The protein-only hypothesis.# f: Z$ A7 q6 ~2 i% w* l

9 Y) H! J1 n  \. W" a; t, S- J  }& YLearning outcomes.
. [, E; `' H4 g; B5 j! N, b& ^" N+ }7 q4 p
Sources of further information.
8 `0 J# l9 ~7 \! E7 T& }. ?% E  Z% c9 C! E9 U4 Z
Virologists' vocabulary.
3 k, P. L, c$ A8 c7 v& K2 |: K
1 J' K2 e% m0 m; G$ ^! rIndex.
附件: 你需要登录才可以下载或查看附件。没有帐号?注册
已有 2 人评分威望 包包 收起 理由
aminhair + 2 + 5 经典书,帖子格式好!
细胞海洋 + 2 + 10 极好资料

总评分: 威望 + 4  包包 + 15   查看全部评分

Rank: 3Rank: 3

积分
364 
威望
364  
包包
131  

优秀会员

沙发
发表于 2011-7-14 19:01 |只看该作者
好书!

Rank: 7Rank: 7Rank: 7

积分
947 
威望
947  
包包
3255  

金话筒 优秀版主

藤椅
发表于 2011-7-14 19:20 |只看该作者
回复 dahui 的帖子
5 n# v  l" b& D, B% A2 [& {" |* f- |, [( Z! ^1 Z
看看

Rank: 3Rank: 3

积分
318 
威望
318  
包包
7  

优秀会员

板凳
发表于 2011-7-14 20:47 |只看该作者
学习

Rank: 1

积分
0 
威望
0  
包包
15  

优秀会员

报纸
发表于 2011-7-14 22:07 |只看该作者
kankan

Rank: 4

积分
2555 
威望
2555  
包包
600  

优秀会员

地板
发表于 2011-7-14 22:17 |只看该作者
3qqq

Rank: 3Rank: 3

积分
410 
威望
410  
包包
39  

优秀会员 金话筒

7楼
发表于 2011-7-14 22:19 |只看该作者
好书,谢谢楼主分享

Rank: 2

积分
160 
威望
160  
包包
3  

帅哥研究员 小小研究员 优秀会员

8楼
发表于 2011-7-14 22:39 |只看该作者
谢谢楼主

Rank: 2

积分
234 
威望
234  
包包
197  

优秀会员

9楼
发表于 2011-7-14 22:39 |只看该作者
好东西

Rank: 2

积分
57 
威望
57  
包包
97  

热心会员 小小研究员 帅哥研究员

10楼
发表于 2011-7-14 23:43 |只看该作者
kankan
‹ 上一主题|下一主题 ›
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2026-11-3 10:33

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.